Claudio Tombazzi is a Transplant Hepatology and Hospice & Palliative Medicine physician at Vanderbilt University Medical Center. He is a 2018 graduate of the University of Tennessee Health Science Center with subsequent Internal Medicine residency, H&PM fellowship, and Gastroenterology and Liver Transplant fellowship at VUMC. His interest is on overlap of palliative medicine and hepatology with special interest on delivery of care in the outpatient setting.

Karl B. Bezak, MD, HMDC is an Assistant Professor of Medicine in the Department of Medicine, Division of General Internal Medicine, Section of Palliative Care and Medical Ethics at the University of Pittsburgh.<br><br>Dr. Bezak completed his medical school training at Vanderbilt University, internal medicine residency at New York Presbyterian Hospital-Weill Cornell Medical Center, and hospice and palliative medicine fellowship at Mount Sinai Hospital in New York City.

Nathan Baggett is an attending emergency physician for HealthPartners in St. Paul, Minnesota. He is a 2017 graduate of the University of Wisconsin School of Medicine and Public Health. He was diagnosed with primary sclerosing cholangitis in 2010. He has received 3 liver transplants in 2017 & 2018.

Teresa Davidson is the Executive Director of the Mid-South Liver Alliance located in Nashville, TN. Mid-South Liver Alliance is committed to improving, educating, advocating, and supporting children, adults, and families impacted by Chronic liver Disease in the mid-South states of TN, KY, AL, MS, AR, and LA. Before becoming the ED for the Mid-South Liver Alliance, Teresa served as a National Engagement Director South for the American Liver Foundation and as CEO for the Tennessee Kidney Foundation.

Bruce Luxon, MD, PhD is chairman and chief of service for the Department of Medicine at Georgetown University Hospital, Washington. His clinical focus is in hepatology, with expertise in autoimmune hepatitis, cholestatic liver diseases and viral hepatitis, including hepatitis B and C. <br><br>Dr. Luxon has served on numerous NIH study sections and the research committees of AASLD and ACG. He is a fellow of the AASLD.

Carolin Lackner is a Professor of Pathology at the Medical University of Graz, Austria. She is specialized in hepatopathology with particular interest in steatotic liver diseases and serves as a central pathologist in clinical trials of MASH.

Nikhil Kalita holds degrees from accelerated programs at the George Washington University. He joined the UC San Diego Health MASLD Research Center in June 2024. His work focuses on coordinating clinical research studies on non-invasive diagnostics of liver disease, focusing on patients with diabetes, cirrhosis, and MASLD. He also contributes to literature reviews and analyzes clinical and national datasets like NHANES to support ongoing research.

Ludovic Saba is a second-year internal medicine resident at UT Southwestern Medical Center in Dallas, TX. He is interested in pursuing a fellowship in gastroenterology and hepatology. His research focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), alcoholic liver disease, and healthcare disparities. Prior to residency, Dr. Saba completed two years of clinical outcomes research at the Cleveland Clinic Florida.

I am a consultant in Hepatology and Professor of Practice in Metabolic Liver Diseases at Imperial College London. My area of expertise, includes MASLD.